SARS-CoV-2_Theta_variant

SARS-CoV-2 Theta variant

SARS-CoV-2 Theta variant

Variant of the SARS-CoV-2 virus


Theta variant, also known as lineage P.3,[lower-alpha 1] is one of the variants of SARS-CoV-2, the virus that causes COVID-19. The variant was first identified in the Philippines on February 18, 2021, when two mutations of concern were detected in Central Visayas.[1] It was detected in Japan on March 12, 2021, when a traveler from the Philippines arrived at Narita International Airport in Tokyo.[2]

It is distinct from those first discovered in the United Kingdom, South Africa, and Brazil, and is thought to pose a similar threat. The variant is more resistant to neutralizing antibodies, including those gained through vaccination, like how the South African and Brazilian variants appear to be.[3]

Under the simplified naming scheme proposed by the World Health Organization, P.3 has been labeled Theta variant, and was considered a variant of interest (VOI), but not a variant of concern.[4]

As of July 2021, Theta is no longer considered as a variant of interest by the WHO.[4]

Classification

Naming

On March 17, 2021, Public Health England (PHE) named Lineage P.3 VUI-21MAR-02.[5]

On June 1, 2021, the World Health Organization (WHO) named lineage P.3 as Theta variant.[6]

Mutations

A total of 14 amino acid replacements were observed in all samples (labeled in red below), including seven spike protein mutations. Among the spike protein mutations, four have been previously associated with lineages of concern (i.e., E484K, N501Y, D614G, and P681H) while three additional replacements were observed towards the C-terminal region of the protein (i.e., E1092K, H1101Y, and V1176F). A single amino acid replacement at the N-terminus of ORF8 (i.e., K2Q) was also found in all samples. Three other mutations were seen in 32 of the 33 samples (labeled in green) including a three-amino acid deletion at the spike protein positions 141 to 143. Lastly, five synonymous mutations (labeled in gray) were also detected in all of the cases.[8]

More information Gene, Amino acid ...
More information Gene, Amino acid ...

History

On February 18, 2021, the Department of Health of the Philippines confirmed the detection of two mutations of COVID-19 in Central Visayas after samples from patients were sent to undergo genome sequencing. The mutations were later named as E484K and N501Y, which were detected in 37 out of 50 samples, with both mutations co-occurrent in 29 out of these. There were no official names for the variants and the full sequence was yet to be identified.[1]

On March 12, 2021, Japan detected the variant on a traveler from the Philippines.[2]

On March 13, 2021, the Department of Health confirmed the mutations constituted a new variant, which was designated as lineage P.3. On the same day, it also confirmed its first case of lineage P.1 in the country. Although the lineages P.1 and P.3 stem from the same lineage B.1.1.28, the department said that the impact of lineage P.3 on vaccine efficacy and transmissibility is yet to be ascertained.[10]

On March 17, 2021, the United Kingdom confirmed its first two cases, where Public Health England (PHE) termed it VUI-21MAR-02.[11]

On April 30, 2021, Malaysia detected 8 cases of lineage P.3 in Sarawak.[12]

Statistics

More information Country, PANGOLIN ...

See also

Notes

  1. Other names include:
    VUI-21MAR-02
    Lineage B.1.1.28.3
    Philippine variant
  2. Cases in Hong Kong.

References

  1. News, CNN Philippines (February 18, 2021). "DOH confirms new COVID-19 mutations in Central Visayas". Archived from the original on November 26, 2021. Retrieved May 2, 2021. {{cite news}}: |last= has generic name (help)
  2. News, Kyodo (March 12, 2021). "New coronavirus variant found in traveler from Philippines: Japan". Retrieved May 2, 2021. {{cite news}}: |last= has generic name (help)
  3. News, Japan Times (March 12, 2021). "Japanese authorities discover a new coronavirus variant in traveler from Philippines". Archived from the original on May 4, 2021. Retrieved May 2, 2021. {{cite news}}: |last= has generic name (help)
  4. "Tracking SARS-CoV-2 variants". who.int. World Health Organization.
  5. "Tracking SARS-CoV-2 variants". June 1, 2021. Retrieved June 1, 2021.
  6. "Spike Variants: Theta variant, aka B.1.128". covdb.stanford.edu. Stanford University Coronavirus Antiviral & Resistance Database. 1 July 2021. Retrieved 2021-07-05.
  7. "P.3 Lineage Report". outbreak.info.
  8. News, ABS-CBN (March 13, 2021). "DOH confirms new COVID-19 variant first detected in PH, first case of Brazil variant". Retrieved May 2, 2021. {{cite news}}: |last= has generic name (help)
  9. News, Rappler (March 17, 2021). "England reports 2 cases of new COVID-19 variant found in Philippines". Retrieved May 2, 2021. {{cite news}}: |last= has generic name (help)
  10. "PANGO lineages". cov-lineages.org. Archived from the original on 2021-05-05. Retrieved 2021-05-02.
  11. "Regeneron COVID-19 Dashboard". covid19dashboard.regeneron.com. Retrieved August 27, 2021.
  12. Lopez, Virgil (September 29, 2021). "DOH detects additional 339 Delta variant cases". GMA News. Retrieved October 1, 2021.
  13. Pei Pei, Goh (July 8, 2021). "Delta variant detected in Sarawak". Retrieved July 13, 2021. He said for the Theta variant, six cases had been detected in Kuching and seven in Kota Samarahan
  14. "Variants: distribution of case data, 13 August 2021". August 13, 2021. Retrieved August 13, 2021.
  15. "Variants in the Netherlands". rivm.nl. Retrieved July 16, 2021.

Share this article:

This article uses material from the Wikipedia article SARS-CoV-2_Theta_variant, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.